{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T11:49:14Z","timestamp":1777031354158,"version":"3.51.4"},"posted":{"date-parts":[[2026,4,21]]},"group-title":"Epidemiology","reference-count":46,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,4,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Non-pharmaceutical interventions (NPIs) have been important for controlling SARS-CoV-2 transmission, particularly before and during initial vaccine rollout. During the pandemic, the US Centers for Disease Control and Prevention issued isolation and masking guidance in case of COVID-19-like illness, a positive SARS-CoV-2 test, or known exposure to SARS-CoV-2. However, the impact of this guidance on mitigating transmission in office workplaces is unclear. We used a network-based mathematical model to estimate the impact of this guidance on SARS-CoV-2 transmission among office workers and their communities. The model represented social contacts in the home, office, and community. We used data from the CorporateMix study to parametrize social contacts among office workers and calibrated the model to represent the COVID-19 epidemic in Georgia, USA from January 2021 through August 2022. In the reference scenario (58% adherence to guidance among office workers and the broader population), workplace transmission accounted for a small fraction of total infections. Reducing adherence among office workers to 0% increased workplace transmissions by 27.1% and increasing adherence to 75% reduced workplace transmission by 7.0%. Increasing adherence to 75% among office workers had minimal impact on symptomatic cases and deaths; increasing it among the broader population was more effective in reducing office worker cases and deaths. In our model, moderate adherence to recommended NPIs in workplaces was effective in reducing transmission, but increasing adherence had limited benefit given workplaces that have low contact intensity and hybrid work arrangements. These results underscore the public health benefits of community-wide adoption of recommended NPIs.<\/jats:p>","DOI":"10.64898\/2026.04.14.26350639","type":"posted-content","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T20:35:20Z","timestamp":1776803720000},"source":"Crossref","is-referenced-by-count":0,"title":["Modeling the impact of adherence to U.S. isolation and masking guidance on SARS-CoV-2 transmission in office workplaces in 2021-2022"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0206-7597","authenticated-orcid":false,"given":"Maria","family":"Garcia Quesada","sequence":"first","affiliation":[{"name":"Rollins School of Public Health, Emory University, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Wallrafen-Sam","sequence":"additional","affiliation":[{"name":"Rollins School of Public Health, Emory University, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moses","family":"Chapa","sequence":"additional","affiliation":[{"name":"Rollins School of Public Health, Emory University, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faruque","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7082-3024","authenticated-orcid":false,"given":"Obianuju Genevieve","family":"Aguolu","sequence":"additional","affiliation":[{"name":"College of Public Heath, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noureen","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Peter O\u2019Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad B.","family":"Omer","sequence":"additional","affiliation":[{"name":"Peter O\u2019Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin A.","family":"Lopman","sequence":"additional","affiliation":[{"name":"Rollins School of Public Health, Emory University, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel M.","family":"Jenness","sequence":"additional","affiliation":[{"name":"Rollins School of Public Health, Emory University, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"issue":"1","key":"2026042404200491000_2026.04.14.26350639v1.1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/jama.2022.21795","article-title":"COVID-19 and Excess All-Cause Mortality in the US and 20 Comparison Countries, June 2021-March 2022","volume":"329","year":"2023","journal-title":"JAMA"},{"key":"2026042404200491000_2026.04.14.26350639v1.2","unstructured":"Centers for Disease Control and Prevention. COVID Data Tracker [Internet]. Centers for Disease Control and Prevention. 2020 [cited 2025 Apr 8]. Available from: https:\/\/covid.cdc.gov\/covid-data-tracker"},{"key":"2026042404200491000_2026.04.14.26350639v1.3","unstructured":"Centers for Disease Control and Prevention. CDC Updates and Shortens Recommended Isolation and Quarantine Period for General Population [Internet]. CDC. 2021 [cited 2024 Oct 28]. Available from: https:\/\/archive.cdc.gov\/www_cdc_gov\/media\/releases\/2021\/s1227-isolation-quarantine-guidance.html"},{"key":"2026042404200491000_2026.04.14.26350639v1.4","unstructured":"Centers for Disease Control and Prevention. Isolation and Precautions for People with COVID-19 [Internet]. Centers for Disease Control and Prevention. 2023 [cited 2024 Oct 28]. Available from: https:\/\/archive.cdc.gov\/www_cdc_gov\/coronavirus\/2019-ncov\/your-health\/isolation.html"},{"key":"2026042404200491000_2026.04.14.26350639v1.5","unstructured":"Centers for Disease Control and Prevention. What to Do If You Were Exposed to COVID-19 [Internet]. 2022 [cited 2024 Oct 28]. Available from: https:\/\/archive.cdc.gov\/www_cdc_gov\/coronavirus\/2019-ncov\/your-health\/if-you-were-exposed.html"},{"key":"2026042404200491000_2026.04.14.26350639v1.6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24115-7"},{"issue":"1","key":"2026042404200491000_2026.04.14.26350639v1.7","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1186\/s12889-024-18377-1","article-title":"Systematic review of empiric studies on lockdowns, workplace closures, and other non-pharmaceutical interventions in non-healthcare workplaces during the initial year of the COVID-19 pandemic: benefits and selected unintended consequences","volume":"24","year":"2024","journal-title":"BMC Public Health"},{"key":"2026042404200491000_2026.04.14.26350639v1.8","doi-asserted-by":"crossref","unstructured":"Kiti MC , Aguolu OG , Zelaya A , Chen HY , Ahmed N , Batross J , et al. Changing social contact patterns among US workers during the COVID-19 pandemic: April 2020 to December 2021. Epidemics. 2023 Dec 1;45:100727.","DOI":"10.1016\/j.epidem.2023.100727"},{"key":"2026042404200491000_2026.04.14.26350639v1.9","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v084.i09"},{"key":"2026042404200491000_2026.04.14.26350639v1.10","unstructured":"National Center for Health Statistics. Bridged-Race Population Estimates [Internet]. 2021 [cited 2024 Oct 31]. Available from: https:\/\/wonder.cdc.gov\/bridged-race-v2020.html"},{"key":"2026042404200491000_2026.04.14.26350639v1.11","unstructured":"United States Department of Labor. Employment status of the civilian noninstitutional population by age, sex, and race [Internet]. Bureau of Labor Statistics. 2024 [cited 2024 Oct 31]. Available from: https:\/\/www.bls.gov\/cps\/cpsaat03.htm"},{"key":"2026042404200491000_2026.04.14.26350639v1.12","doi-asserted-by":"crossref","unstructured":"Fisher KA , Tenforde MW , Feldstein LR , Lindsell CJ , Shapiro NI , Files DC , et al. Community and Close Contact Exposures Associated with COVID-19 Among Symptomatic Adults \u226518 Years in 11 Outpatient Health Care Facilities \u2014 United States, July 2020. MMWR Morb Mortal Wkly Rep. 2020 Sept 11;69(36):1258\u201364.","DOI":"10.15585\/mmwr.mm6936a5"},{"key":"2026042404200491000_2026.04.14.26350639v1.13","doi-asserted-by":"crossref","unstructured":"Wallrafen-Sam K , Quesada MG , Lopman BA , Jenness SM . Modelling the Interplay between Responsive Individual Vaccination Decisions and the Spread of SARS-CoV-2. Epidemics. 2025 Apr 23;100831.","DOI":"10.1016\/j.epidem.2025.100831"},{"key":"2026042404200491000_2026.04.14.26350639v1.14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi"},{"key":"2026042404200491000_2026.04.14.26350639v1.15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249891"},{"key":"2026042404200491000_2026.04.14.26350639v1.16","doi-asserted-by":"crossref","unstructured":"Oeltmann JE , Vohra D , Matulewicz HH , DeLuca N , Smith JP , Couzens C , et al. Isolation and Quarantine for Coronavirus Disease 2019 in the United States, 2020\u20132022. Clin Infect Dis. 2023 July 26;77(2):212\u20139.","DOI":"10.1093\/cid\/ciad163"},{"key":"2026042404200491000_2026.04.14.26350639v1.17","unstructured":"Centers for Disease Control and Prevention. COVID-19 Vaccinations in the United States, Jurisdiction [Internet]. Centers for Disease Control and Prevention. 2023 [cited 2024 Nov 3]. Available from: https:\/\/data.cdc.gov\/Vaccinations\/COVID-19-Vaccinations-in-the-United-States-Jurisdi\/unsk-b7fc\/about_data"},{"key":"2026042404200491000_2026.04.14.26350639v1.18","unstructured":"Institute for Health Metrics and Evaluation, University of Washington. IHME: COVID-19 Projections [Internet]. Institute for Health Metrics and Evaluation. 2022 [cited 2024 Nov 3]. Available from: https:\/\/covid19.healthdata.org\/"},{"key":"2026042404200491000_2026.04.14.26350639v1.19","unstructured":"Georgia Department of Public Health. Georgia COVID-19 Dashboard [Internet]. [cited 2024 Nov 3]. Available from: https:\/\/ga-covid19.ondemand.sas.com\/"},{"key":"2026042404200491000_2026.04.14.26350639v1.20","unstructured":"Hallas L , Hatibie A , Koch R , Majumdar S , Pyarali M , Wood A , et al. Variation in US states\u2019 COVID-19 policy responses [Internet]. University of Oxford; 2021 May [cited 2025 July 25]. (BSG Working Paper Series). Available from: https:\/\/www.bsg.ox.ac.uk\/sites\/default\/files\/2021-05\/BSG-WP-2020-034-v3.pdf"},{"key":"2026042404200491000_2026.04.14.26350639v1.21","unstructured":"Redmond SWP and JJ. The rise in remote work since the pandemic and its impact on productivity [Internet]. Bureau of Labor Statistics. 2024 [cited 2025 July 25]. Available from: https:\/\/www.bls.gov\/opub\/btn\/volume-13\/remote-work-productivity.htm"},{"key":"2026042404200491000_2026.04.14.26350639v1.22","doi-asserted-by":"crossref","unstructured":"Hu S , Xiong C , Zhao Y , Yuan X , Wang X. Vaccination, human mobility, and COVID-19 health outcomes: Empirical comparison before and during the outbreak of SARS-Cov-2 B.1.1.529 (Omicron) variant. Vaccine. 2023 Aug;41(35):5097\u2013112.","DOI":"10.1016\/j.vaccine.2023.05.056"},{"key":"2026042404200491000_2026.04.14.26350639v1.23","doi-asserted-by":"crossref","unstructured":"Bouzaghrane MA , Obeid H , Gonz\u00e1lez M , Walker J . Human mobility reshaped? Deciphering the impacts of the Covid-19 pandemic on activity patterns, spatial habits, and schedule habits. EPJ Data Sci [Internet]. 2024 Mar 22 [cited 2025 July 23];13(1). Available from: https:\/\/epjdatascience.springeropen.com\/articles\/10.1140\/epjds\/s13688-024-00463-4","DOI":"10.1140\/epjds\/s13688-024-00463-4"},{"key":"2026042404200491000_2026.04.14.26350639v1.24","doi-asserted-by":"crossref","unstructured":"Wang P , Yuan Y . Analyzing Key Factors Influencing Human Mobility Before and During COVID-19 With Explainable Machine Learning. Trans GIS [Internet]. 2025 Feb [cited 2025 July 23];29(1). Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tgis.13271","DOI":"10.1111\/tgis.13271"},{"key":"2026042404200491000_2026.04.14.26350639v1.25","doi-asserted-by":"crossref","unstructured":"Lessler J , Grabowski MK , Grantz KH , Badillo-Goicoechea E , Metcalf CJE , Lupton-Smith C , et al. Household COVID-19 risk and in-person schooling. Science. 2021 June 4;372(6546):1092\u20137.","DOI":"10.1126\/science.abh2939"},{"key":"2026042404200491000_2026.04.14.26350639v1.26","unstructured":"U.S. Census Bureau. U.S. Census Bureau QuickFacts: Georgia [Internet]. 2021. Available from: https:\/\/www.census.gov\/quickfacts\/fact\/table\/GA\/PST045221"},{"key":"2026042404200491000_2026.04.14.26350639v1.27","unstructured":"U.S. Census Bureau. Table H2. Households, by Type, Age of Members, Region of Residence, and Age of Householder: 2020 [Internet]. 2020. Available from: https:\/\/www2.census.gov\/programs-surveys\/demo\/tables\/families\/2020\/cps-2020\/tabh2-all.xls"},{"key":"2026042404200491000_2026.04.14.26350639v1.28","unstructured":"U.S. Census Bureau. Table C4. Children with Grandparents by Presence of Parents, Sex, and Selected Characteristics: 2021 [Internet]. 2021. Available from: https:\/\/www2.census.gov\/programs-surveys\/demo\/tables\/families\/2021\/cps-2021\/tabc4-all.xls"},{"issue":"7","key":"2026042404200491000_2026.04.14.26350639v1.29","doi-asserted-by":"crossref","first-page":"e375","DOI":"10.1016\/S2468-2667(20)30133-X","article-title":"Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study","volume":"5","year":"2020","journal-title":"Lancet Public Health"},{"key":"2026042404200491000_2026.04.14.26350639v1.30","unstructured":"Harrington K. Covid-19 Mitigation Strategies: Implications for Pandemic Control and the Incidence of Drug-Resistant Tuberculosis. 2022."},{"key":"2026042404200491000_2026.04.14.26350639v1.31","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab746"},{"key":"2026042404200491000_2026.04.14.26350639v1.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2021.02.012"},{"key":"2026042404200491000_2026.04.14.26350639v1.33","unstructured":"Centers for Disease Control and Prevention. Science brief: SARS-COV-2 infection induced and vaccine-induced immunity [Internet]. 2021 Oct. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/science\/science-briefs\/vaccine-induced-immunity.html"},{"key":"2026042404200491000_2026.04.14.26350639v1.34","unstructured":"Georgia Department of Public Health, Office of Health INdicators for Planning . OASIS Web Query - Mortality Statistics [Internet]. Online Analytical Statistical Information System (OASIS); Available from: https:\/\/oasis.state.ga.us\/oasis\/WebQuery\/qryMortality.aspx"},{"key":"2026042404200491000_2026.04.14.26350639v1.35","unstructured":"Centers for Disease Control and Prevention. CDC recommends COVID-19 vaccines for young children [Internet]. 2020 June. Available from: https:\/\/www.cdc.gov\/media\/releases\/2022\/s0618-children-vaccine.html"},{"key":"2026042404200491000_2026.04.14.26350639v1.36","unstructured":"Mandavilli A. C.D.C Advisers Endorse Pfizer Vaccine for Children Ages 12 to 15. The New York Times [Internet]. 2021 May 12; Available from: https:\/\/www.nytimes.com\/2021\/05\/12\/health\/coronavirus-vaccine-children.html"},{"key":"2026042404200491000_2026.04.14.26350639v1.37","unstructured":"Bluestein G , Oliviero H , Stirgus E. All Georgia adults will be eligible for coronavirus vaccines starting Thursday. The Atlanta Journal-Constitution [Internet]. 2021 Mar 23; Available from: https:\/\/www.ajc.com\/politics\/S2TLG4G3CBDNJBUPPRROV5ROSI\/"},{"key":"2026042404200491000_2026.04.14.26350639v1.38","unstructured":"Stirgus E , Bluestein G , Trubey J. Georgia to allow 55+ and \u201chigh-risk\u201d residents to get coronavirus vaccine. The Atlanta Journal-Constitution [Internet]. 2021 Mar 10; Available from: https:\/\/www.ajc.com\/politics\/PO4VMZ3Q3NA25LPQB6CNDW7PAA\/"},{"key":"2026042404200491000_2026.04.14.26350639v1.39","unstructured":"Peck S. Georgia Expands COVID-19 Vaccine Availability to Include People Age 65 or Older, Northeast Health District Opens Drive-Through Vaccination Clinic. Northeast Health District [Internet]. 2021 Jan 22; Available from: https:\/\/publichealthathens.com\/wp\/wp-content\/uploads\/2021\/01\/COVID-19-Vaccination-Drive-Through-Release-01112021.pdf"},{"key":"2026042404200491000_2026.04.14.26350639v1.40","unstructured":"U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine. 2022; Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-takes-multiple-actions-expand-use-pfizer-biontech-covid-19-vaccine"},{"key":"2026042404200491000_2026.04.14.26350639v1.41","unstructured":"Centers for Disease Control and Prevention. CDC Expands Eligibility for COVID-19 Booster Shots to All Adults. 2021 Nov 19; Available from: https:\/\/www.cdc.gov\/media\/releases\/2021\/s1119-booster-shots.html"},{"key":"2026042404200491000_2026.04.14.26350639v1.42","unstructured":"U.S. Food and Drug Administration. FDA authorizes booster dose of Pfizer-BioNTech COVID-19 vaccine for certain populations. 2021 Sept 22; Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-authorizes-booster-dose-pfizer-biontech-covid-19-vaccine-certain-populations"},{"key":"2026042404200491000_2026.04.14.26350639v1.43","unstructured":"U.S. Food and Drug Administration. Coronavirus (COVID-19) update: FDA authorizes second booster dose of two COVID-19 vaccines for older and immunocompromised individuals. 2022 Mar 29; Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-authorizes-second-booster-dose-two-covid-19-vaccines-older-and"},{"key":"2026042404200491000_2026.04.14.26350639v1.44","doi-asserted-by":"crossref","unstructured":"Pilishvili T , Gierke R , Fleming-Dutra KE , Farrar JL , Mohr NM , Talan DA , et al. Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel. N Engl J Med [Internet]. 2021 Dec 16 [cited 2025 July 25];385(25). Available from: http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2106599","DOI":"10.1056\/NEJMoa2106599"},{"key":"2026042404200491000_2026.04.14.26350639v1.45","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-4266736(21)02249-2"},{"key":"2026042404200491000_2026.04.14.26350639v1.46","doi-asserted-by":"crossref","unstructured":"Chung H , He S , Nasreen S , Sundaram ME , Buchan SA , Wilson SE , et al. Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study. BMJ. 2021 Aug 20;n1943.","DOI":"10.1136\/bmj.n1943"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.04.14.26350639","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T11:20:36Z","timestamp":1777029636000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.04.14.26350639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":46,"URL":"https:\/\/doi.org\/10.64898\/2026.04.14.26350639","relation":{},"subject":[],"published":{"date-parts":[[2026,4,21]]},"subtype":"preprint"}}